UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000030884
Receipt No. R000035262
Scientific Title A comparison of remission rate at 8 weeks between combination therapy of Ustekinumab and Budesonide and monotherapy of Ustekinumab in moderate to severe Japanese Crohn's disease; A phase III, single-center, double blind, randomized control trial.
Date of disclosure of the study information 2018/02/20
Last modified on 2019/07/23 11:08:29

No. Disposal Last modified on Item of update
1 Insert 2018/01/18 20:57:37
2 Update 2018/02/19 08:34:50 Public title
3 Update 2018/02/19 09:13:31 Primary outcomes
Key secondary outcomes
4 Update 2018/02/19 09:16:07 Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
Key exclusion criteria
5 Update 2018/07/20 16:05:17 Recruitment status
6 Update 2019/07/23 11:06:43 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Email3
Organization
Organization
Address
Address
Tel
Email
7 Update 2019/07/23 11:08:29 Date of IRB
Last follow-up date


Contact us.